An Overview of Concentrated Insulin Products

IN BRIEF This article provides a summary of the use of available concentrated insulins in the outpatient treatment of patients with diabetes. Concentrated insulins work through the same mechanisms as other insulin products. They vary from each other in concentrations and pharmacokinetic/pharmacodyna...

Descripción completa

Detalles Bibliográficos
Autores principales: Painter, Nathan A., Sisson, Evan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2016
Materias:
From Research to Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5001226/
https://www.ncbi.nlm.nih.gov/pubmed/27574366
http://dx.doi.org/10.2337/diaspect.29.3.136
_version_ 1782450434722496512
author Painter, Nathan A.
Sisson, Evan
author_facet Painter, Nathan A.
Sisson, Evan
author_sort Painter, Nathan A.
collection PubMed
description IN BRIEF This article provides a summary of the use of available concentrated insulins in the outpatient treatment of patients with diabetes. Concentrated insulins work through the same mechanisms as other insulin products. They vary from each other in concentrations and pharmacokinetic/pharmacodynamics profiles but are each similar to their U-100 concentration counterparts. Patient education is important to minimize errors and the risk of hypoglycemia when using these insulin formulations.
format Online
Article
Text
id pubmed-5001226
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-50012262017-08-01 An Overview of Concentrated Insulin Products Painter, Nathan A. Sisson, Evan Diabetes Spectr From Research to Practice IN BRIEF This article provides a summary of the use of available concentrated insulins in the outpatient treatment of patients with diabetes. Concentrated insulins work through the same mechanisms as other insulin products. They vary from each other in concentrations and pharmacokinetic/pharmacodynamics profiles but are each similar to their U-100 concentration counterparts. Patient education is important to minimize errors and the risk of hypoglycemia when using these insulin formulations. American Diabetes Association 2016-08 /pmc/articles/PMC5001226/ /pubmed/27574366 http://dx.doi.org/10.2337/diaspect.29.3.136 Text en © 2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0 for details.
spellingShingle From Research to Practice
Painter, Nathan A.
Sisson, Evan
An Overview of Concentrated Insulin Products
title An Overview of Concentrated Insulin Products
title_full An Overview of Concentrated Insulin Products
title_fullStr An Overview of Concentrated Insulin Products
title_full_unstemmed An Overview of Concentrated Insulin Products
title_short An Overview of Concentrated Insulin Products
title_sort overview of concentrated insulin products
topic From Research to Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5001226/
https://www.ncbi.nlm.nih.gov/pubmed/27574366
http://dx.doi.org/10.2337/diaspect.29.3.136
work_keys_str_mv AT painternathana anoverviewofconcentratedinsulinproducts
AT sissonevan anoverviewofconcentratedinsulinproducts
AT painternathana overviewofconcentratedinsulinproducts
AT sissonevan overviewofconcentratedinsulinproducts

Ejemplares similares